To include your compound in the COVID-19 Resource Center, submit it here.

Medivir, Boehringer Ingelheim International GmbH deal

By WIR Staff | Jul 21, 2003 | 7:00 AM GMT

MVIR granted Boehringer exclusive worldwide marketing rights

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE